- 21 September
-
On September 11–17, 2026, Ekaterinburg hosted the International Youth Festival, a large-scale event that brought together 10,000 young leaders from 191 countries. At the festival running under the motto «Follow Your Dream,» the Medsintez Plant presented its exhibition, showcasing the achievements of the Ural pharmaceutical industry in the field of import substitution.
- 18 September
-
The updated clinical guidelines for treatment of ARVI in children took effect on September 2, 2026. The document was developed by leading experts from the Union of Pediatricians of Russia, the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC), and the Russian Society of Emergency Medical Care and approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation. It fundamentally shifts therapeutic approaches toward enhanced safety and minimal drug burden.
- 14 September
-
On September 3–4, 2026, Nizhny Novgorod hosted the 2nd Regional Endocrinological Congress: Challenges and Prospects of the Volga Region, with the active participation of the Medsintez Plant. As a strategic company, Medsintez Plant has been ensuring Russia's pharmaceutical security for 25 years. Company's exhibition booth showcased a range of hormonal medications for treatment of type 1 and type 2 diabetes, as well as drugs for infertility treatment through the IVF method.
- 04 September
-
More than twenty years ago, the Regiony Rossii (Regions of Russia, RR) magazine witnessed the birth of an innovative pharmaceutical production facility in Novouralsk, which had no analogues in the country. Today, the Medsintez Plant is a strategic asset in terms of national pharmaceutical security, a recognized industry leader, a National Champion, and a winner of prestigious awards. The secret behind the success of the Ural school of pharmaceuticals and biotechnology is explored in this article by RR.
- Home
- Cluster members
- Paradigma LLC
Paradigma LLC
Paradigma LLC is a dynamically developing company specializing in the production and treatment of medical devices. The company successfully operates in the market of medical products and offers comprehensive solutions for health care facilities.
Main areas of activity
- Production of KAP (a liquid embolic system) – manufacturing of specialized medical systems
- Production of syringe kits – manufacturing of components for medical equipment
- Sterilization services – professional treatment of medical devices
Paradigma LLC has launched a sterilization center of (low-temperature) gas sterilization, which allows us to manufacture sterile medical products for the end user. The production capacity of the company allows it to sterilize not only its own products, but also to provide sterilization services to third-party customers.
For the convenience of our customers, we offer services for packaging products in corrugated boxes. The customer can place an order for sterilization of one corrugated box, one cubic meter, or fill the entire useful capacity of the gas chamber with their products. The price of the sterilization service is set individually depending on the volume of products, duration and mode of the cycle.
We have equipped our own high-tech production facilities for the manufacture of syringe kits suitable for a wide range of devices for the intravenous administration of radiopaque substances, which allows us to control the product quality at all stages.
- Quality control at all stages of production. Use of modern technologies and equipment. Wide range of products.
- Flexibility in production of individual orders.
- Our syringe kits meet all quality requirements and standards, which is confirmed by the relevant certificates.
- We offer our customers favorable terms of cooperation, individual approach and fast delivery of products.
Own production of KAP
Sterile, non-absorbable, non-adhesive, X-ray contrast polymer implant for embolization of vascular lesions in various clinical situations. It can be used, among other things, for embolization in case of cerebral vascular pathology, including arteriovenous malformations and hypervascular tumors.
KAP is a liquid embolic system made of the following components:
Ethylene-vinyl alcohol copolymer (EVOH)
Dimethyl sulfoxide (DMSO)
Micronized tantalum powder (Ta)
KAP is able to penetrate into the bloodstream to a given depth (depending on the selected viscosity), thereby ensuring total occlusion of target vessels.
40/4 Gurzufskaya St., 620102 Ekaterinburg
Tel.: (343) 286-14-57
E-mail: paradigma2000@mail.ru
www.angio.pro
